Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Shanghai Model Organisms Center's Revenue for the
three
months ended in Jun. 2026 was ¥132.5 Mil. Shanghai Model Organisms Center's average Accounts Receivable for the
three
months ended in Jun. 2026 was ¥149.1 Mil.
Hence, Shanghai Model Organisms Center's Receivables Turnover for the
three
months ended in Jun. 2026 was 0.89.
Shanghai Model Organisms Center (SHSE:688265) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Shanghai Model Organisms Center Receivables Turnover Related Terms
Shanghai Model Organisms Center Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Model Organisms Center Receivables Turnover Chart
SHSE:688265 vs VRTX, REGN, MRNA: Receivables Turnover Comparison
For the Biotechnology subindustry, Shanghai Model Organisms Center's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Model Organisms Center Receivables Turnover vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanghai Model Organisms Center's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Shanghai Model Organisms Center's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Model Organisms Center (SHSE:688265) has a Receivables Turnover of 0.89 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Shanghai Model Organisms Center and its competitors. According to the industry distribution chart, Shanghai Model Organisms Center ranks #624 out of 853 companies in the Biotechnology industry, placing it in the top 73.2%.
Is Shanghai Model Organisms Center's Receivables Turnover too high?
Shanghai Model Organisms Center's current Receivables Turnover is 0.89. The Biotechnology industry median Receivables Turnover is 5.28. Shanghai Model Organisms Center's value of 0.89 is 83.1% below this industry median. Based on the distribution chart, Shanghai Model Organisms Center ranks #624 out of 853 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Shanghai Model Organisms Center has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Model Organisms Center's Receivables Turnover compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Model Organisms Center ranks #624 out of 853 companies for Receivables Turnover. This places Shanghai Model Organisms Center in the lower half of its industry. The industry median Receivables Turnover is 5.28. Shanghai Model Organisms Center's value of 0.89 is 83.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Biotechnology company?
The median Receivables Turnover among Biotechnology companies is 5.28, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Model Organisms Center's current Receivables Turnover of 0.89 is 83.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Shanghai Model Organisms Center and its competitors. For the Biotechnology industry, the median Receivables Turnover is 5.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Model Organisms Center's current Receivables Turnover is 0.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Model Organisms Center stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Model Organisms Center (SHSE:688265) is currently considered Fairly Valued. The stock's GF Value™ is ¥39.26, compared to a current price of ¥39.67 — trading 1% above its estimated fair value. The current Receivables Turnover is 0.89 and 83.1% below the Biotechnology industry median of 5.28. Shanghai Model Organisms Center's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Shanghai Model Organisms Center (SHSE:688265), the current Receivables Turnover is 0.89 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Model Organisms Center (SHSE:688265) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Model Organisms Center stock appears to be overvalued.
The current stock price of ¥39.67 is trading 1% above its estimated GF Value™ of ¥39.26.
GuruFocus considers Shanghai Model Organisms Center to be Fairly Valued.
Key valuation signals for SHSE:688265:
Receivables Turnover: 0.89
GF Value™: ¥39.26 vs. price of ¥39.67 (1% above fair value)
Industry Position: 83.1% below the Biotechnology median (#624 of 853)
No single metric tells the full story. See the SHSE:688265 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Model Organisms Center Inc is engaged in model organisms and is dedicated to gene editing and life decoding. It provides customized solutions such as genetically engineered animal models, phenotype analysis and high-throughput screenings to advance life science research and drug discovery.
80GF Score
Get the complete analysis for SHSE:688265
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688265 has been successfully added to your 
